Hematologic Oncology Update
Un pódcast de Research To Practice
561 Episodo
-
HOU0110 | Interview with Keith Stewart, MBChB
Publicado: 16/3/2010 -
HOU0110 | CME Information and Program PDF
Publicado: 16/3/2010 -
ASH10_NHLCLL | Roundtable discussion on NHL and CLL with Stephanie A Gregory, MD, Jonathan W Friedberg, MD, Fredrick B Hagemeister, MD, David G Maloney, MD, PhD, Kanti R Rai, MD and Wyndham H Wilson,
Publicado: 8/3/2010 -
ASH10_NHLCLL | CME Information and Program PDF
Publicado: 8/3/2010 -
ASHRounds10 | Case-based discussion on Myelodysplastic Syndrome/Acute Myeloid Leukemia with Aristoteles Giagounidis, MD, PhD and Gail J Roboz, MD
Publicado: 8/3/2010 -
ASHRounds10 | Case-based discussion on Multiple Myeloma with Edward A Stadtmauer, MD and David H Vesole, MD, PhD
Publicado: 24/2/2010 -
ASHRounds10 | Case-based discussion on Chronic Myeloid Leukemia with Michael J Mauro, MD and Susan M O’Brein, MD
Publicado: 24/2/2010 -
ASHRounds10 | Faculty Q&A discussion with Aristoteles Giagounidis, MD, PhD, Michael J Mauro, MD, Susan M O’Brien, MD, Gail J Roboz, MD, Edward A Stadtmauer, MD and David H Vesole, MD, PhD
Publicado: 24/2/2010 -
ASHRounds10 | CME Information and Program PDF
Publicado: 24/2/2010 -
HOU4 2009 | Interview with Sergio Giralt, MD
Publicado: 30/11/2009 -
HOU4 2009 | Interview with Julie M Vose, MD
Publicado: 30/11/2009 -
HOU4 2009 | Interview with Allen SR Yang, MD, PhD
Publicado: 30/11/2009 -
HOU4 2009 | Interview with Michael J Mauro, MD
Publicado: 30/11/2009 -
HOU4 2009 | CME Information and Program PDF
Publicado: 30/11/2009 -
HOU3 2009 | Interview with Jonathan W Friedberg, MD
Publicado: 1/10/2009 -
HOU3 2009 | Interview with Nikhil C Munshi, MD
Publicado: 1/10/2009 -
HOU3 2009 | Interview with Vicki A Morrison, MD
Publicado: 1/10/2009 -
HOU3 2009 | Interview with Elias Jabbour, MD
Publicado: 1/10/2009 -
HOU3 2009 | CME Information and Program PDF
Publicado: 1/10/2009 -
HOUJC1 2009 | Case 1
Publicado: 16/7/2009
Featuring one-on-one interviews conducted by Dr Neil Love, this series provides medical oncologists with access to an array of important perspectives and information on relevant advances in the treatment of hematologic cancer to facilitate optimal patient care.
